[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342161-105":59,"doc-detail-342161-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","ska123-is-a-prognostic-and-predictive-biomarker-in-esophageal-adenocarcinoma-and-squamous-cell-carcinoma-research-open-access","SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma - Research Open Access","","Esophageal carcinoma remains a leading malignant tumor worldwide, yet the 5-year survival rate is still unsatisfactory despite therapeutic advances. The spindle and kinetochore associated complex subunits SKA1/2/3 attach to the kinetochore during mitosis, and are implicated in tumor development. This study evaluates SKA1/2/3 expression, diagnostic relevance, and prognostic value in ESCA, and explores potential regulatory mechanisms and associated biology.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ska123-is-a-prognostic-and-predictive-biomarker-in-esophageal-adenocarcinoma-and-squamous-cell-carcinoma-research-open-access/342161/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ska123-is-a-prognostic-and-predictive-biomarker-in-esophageal-adenocarcinoma-and-squamous-cell-carcinoma-research-open-access/342161.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this study on SKA1/2/3 in ESCA?","Question",{"text":112,"@type":113},"To determine how SKA1/2/3 is expressed in esophageal carcinoma, assess its diagnostic value and prognostic implications, and explore possible regulatory mechanisms in ESCA.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases were used to analyze SKA1/2/3 in ESCA patients?",{"text":117,"@type":113},"TCGA, UALCAN, Kaplan-Meier Plotter, and TIMER databases were used to evaluate expression patterns, prognosis, diagnostic value, and related regulatory insights.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological processes and pathways were suggested by co-expressed gene enrichment?",{"text":121,"@type":113},"Genes co-expressed with SKA1/2/3 were enriched in the cell cycle, DNA replication, and the p53 signaling pathway.",{"name":123,"@type":110,"acceptedAnswer":124},"How does SKA1/2/3 affect ESCA cell behavior according to the study?",{"text":125,"@type":113},"Silencing SKA1/2/3 significantly suppresses ESCA cell proliferation and migration and promotes apoptosis, supporting a functional role in tumor progression.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},342161,1790616253,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Zhang et al. BMC Cancer (2024) 24:1480 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-13257-8](https://doi.org/10.1186/s12885-024-13257-8)  \nRESEARCH Open Access  \nSKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma  \nLiming Zhang 1,2, Shaoqiang Wang3 and Lina Wang 1,4*  \nAbstract  \nBackground Esophageal carcinoma (ESCA) ranks among the most prevalent malignant tumors globally. Despite significant advancements in treatment options and improved patient outcomes, the 5-year survival rate remains unsatisfactory. The spindle and kinetochore associated complex subunit 1/2/3 (SKA1/2/3) attached to the kinetochore (KT) in the metaphase of mitosis are implicated in the occurrence and development of various tumors. However, the expression patterns, diagnostic significance and prognostic implications of SKA1/2/3 in ESCA have not been comprehensively determined.  \nMethods TCGA, UALCAN, Kaplan-Meier Plotter, and TIMER databases were leveraged to dissect the expression patterns, prognostic implications and diagnostic value of SKA1/2/3 in ESCA patients, as well as to investigate the potential regulatory mechanism of SKA1/2/3 in the onset and progression of ESCA.  \nResults In ESCA, SKA1/2/3 exhibited substantial expression, with higher levels relating significantly with clinicopathological features and patient prognosis. Enrichment analysis of genes co-expressed with SKA1/2/3 highlighted their involvement in the cell cycle, DNA replication and p53 signaling pathway. Protein-protein interaction (PPI) analysis identified ten hub genes that were not only markedly upregulated but also portended a poor prognosis in ESCA. Additionally, immune infiltration assays uncovered a significant link between SKA1/2/3 expression and the immune cell infiltration within ESCA. Silencing of SKA1/2/3 significantly suppresses cell proliferation and migration, while concurrently promoting apoptosis in ESCA cells.  \nConclusions SKA1/2/3 may serve as promising biomarkers for the prognosis and diagnosis of ESCA, which holds promise as a novel therapeutic target for the disease.  \nKeywords SKA1/2/3, Esophageal carcinoma (ESCA), Prognostic biomarker, Diagnosis, Bioinformatics analysis  \n*Correspondence:  \nLina Wang  \n[wanglina_china@163.com](wanglina_china@163.com)  \n1Medical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong Province 272029, P. R. China 2Department of Thoracic Surgery, Weifang Second People’s Hospital, Weifang, Shandong Province 261041, P. R. China  \n3Department of Thoracic Surgery, Weifang People’s Hospital, Weifang, Shandong Province 261000, P. R. China  \n4Medical Research Center, Affiliated Hospital of Jining Medical University, 89 Guhuai Road, Jining, Shandong Province 272029, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nIntroduction  \nEsophageal carcinoma (ESCA) is among the most commonly diagnosed malignan","cbCaicEGqXnO8Mgb","https://ap.wps.com/l/cbCaicEGqXnO8Mgb","pdf",3960484,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords","[{\"question\":\"What is the main purpose of this study on SKA1/2/3 in ESCA?\",\"answer\":\"To determine how SKA1/2/3 is expressed in esophageal carcinoma, assess its diagnostic value and prognostic implications, and explore possible regulatory mechanisms in ESCA.\"},{\"question\":\"Which databases were used to analyze SKA1/2/3 in ESCA patients?\",\"answer\":\"TCGA, UALCAN, Kaplan-Meier Plotter, and TIMER databases were used to evaluate expression patterns, prognosis, diagnostic value, and related regulatory insights.\"},{\"question\":\"What biological processes and pathways were suggested by co-expressed gene enrichment?\",\"answer\":\"Genes co-expressed with SKA1/2/3 were enriched in the cell cycle, DNA replication, and the p53 signaling pathway.\"},{\"question\":\"How does SKA1/2/3 affect ESCA cell behavior according to the study?\",\"answer\":\"Silencing SKA1/2/3 significantly suppresses ESCA cell proliferation and migration and promotes apoptosis, supporting a functional role in tumor progression.\"}]","SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma - Research Open Access | PDF",1790045594,48,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4aa41d473ea05b6d321cad7a6e3501f4.webp",983,1310,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf6f36307bcf2c058ed72f2acd3352aa.webp",982,1309,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5417d3f913b9120d5e87f586517d4763.webp",981,1308,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60c19d31d6104e786711a03ed751d198.webp",980,1306]